|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/06 | |
| A61K 9/08 | |||
| A61K 47/36 | |||
| A61K 31/573 | |||
| A61P 29/00 |
| (11) | Number of the document | 2948182 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14704239.4 |
| Date of filing the European patent application | 2014-01-23 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/012824 |
| Date | 2014-01-23 |
| (87) | Number | WO 2014/116876 |
| Date | 2014-07-31 |
| (30) | Number | Date | Country code |
| 201361755723 P | 2013-01-23 | US | |
| 201361776617 P | 2013-03-11 | US |
| (72) |
SHAH, Mahendra, G., US
|
| (73) |
Semnur Pharmaceuticals, Inc.,
960 San Antonio Road Suite 100, Palo Alto, CA 94303,
US
|
| (54) | PHARMACEUTICAL FORMULATION COMPRISING AN INSOLUBLE CORTICOSTEROID AND A SOLUBLE CORTICOSTEROID |
| PHARMACEUTICAL FORMULATION COMPRISING AN INSOLUBLE CORTICOSTEROID AND A SOLUBLE CORTICOSTEROID |